Johan Deniaud

UMR 703, Oniris, INRAE, Route De Gachet, CS 40706
Nantes, 44307, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Accumulation of membrane repair-associated proteins and mature myostatin are novel markers of muscle pathophysiology in Pompe disease.

Accumulation of membrane repair-associated proteins and mature myostatin are novel markers of muscle pathophysiology in Pompe disease.

Journal: Acta neuropathologica communications

Published: January 14, 2026

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?

Journal: Molecular therapy. Methods & clinical development

Published: March 10, 2020

Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II).

Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II).

Journal: Acta neuropathologica communications

Published: August 17, 2018

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.

Journal: Acta neuropathologica communications

Published: July 21, 2017

Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.

Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.

Journal: Gene therapy

Published: November 11, 2016

Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.

Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.

Journal: Human gene therapy. Clinical development

Published: March 12, 2015

Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats.

Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats.

Journal: Gene therapy

Published: April 14, 2014

Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.

Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.

Journal: Gene therapy

Published: August 13, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026